Artículos de revistas
First description of rpsJ and mepA mutations associated with tigecycline resistance in Staphylococcus aureus isolated from a cystic fibrosis patient during antibiotic therapy
Fecha
2017-10Registro en:
Haim, Maria Sol; Di Gregorio, Sabrina Noelia; Galanternik, L.; Lubovich, S.; Vázquez, M.; et al.; First description of rpsJ and mepA mutations associated with tigecycline resistance in Staphylococcus aureus isolated from a cystic fibrosis patient during antibiotic therapy
; Elsevier Science; International Journal of Antimicrobial Agents; 50; 6; 10-2017; 739-741
0924-8579
1872-7913
CONICET Digital
CONICET
Autor
Haim, Maria Sol
Di Gregorio, Sabrina Noelia
Galanternik, L.
Lubovich, S.
Vázquez, M.
Zaheer, A.
Golding, G. R.
Graham, M.
Van Domselaar, G.
Cardona, S. T.
Mollerach, Marta Eugenia
Bharat, R.
Resumen
First description of rpsJ and mepA mutations associated with tigecycline resistance in Staphylococcus aureus isolated from a cystic fibrosis patient during antibiotic therapy.